Correlation Between Diamyd Medical and XTANT MEDICAL

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Diamyd Medical and XTANT MEDICAL at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Diamyd Medical and XTANT MEDICAL into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Diamyd Medical AB and XTANT MEDICAL HLDGS, you can compare the effects of market volatilities on Diamyd Medical and XTANT MEDICAL and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Diamyd Medical with a short position of XTANT MEDICAL. Check out your portfolio center. Please also check ongoing floating volatility patterns of Diamyd Medical and XTANT MEDICAL.

Diversification Opportunities for Diamyd Medical and XTANT MEDICAL

0.05
  Correlation Coefficient

Significant diversification

The 3 months correlation between Diamyd and XTANT is 0.05. Overlapping area represents the amount of risk that can be diversified away by holding Diamyd Medical AB and XTANT MEDICAL HLDGS in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on XTANT MEDICAL HLDGS and Diamyd Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Diamyd Medical AB are associated (or correlated) with XTANT MEDICAL. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of XTANT MEDICAL HLDGS has no effect on the direction of Diamyd Medical i.e., Diamyd Medical and XTANT MEDICAL go up and down completely randomly.

Pair Corralation between Diamyd Medical and XTANT MEDICAL

Assuming the 90 days horizon Diamyd Medical AB is expected to generate 2.55 times more return on investment than XTANT MEDICAL. However, Diamyd Medical is 2.55 times more volatile than XTANT MEDICAL HLDGS. It trades about 0.36 of its potential returns per unit of risk. XTANT MEDICAL HLDGS is currently generating about -0.13 per unit of risk. If you would invest  95.00  in Diamyd Medical AB on September 25, 2024 and sell it today you would earn a total of  41.00  from holding Diamyd Medical AB or generate 43.16% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Diamyd Medical AB  vs.  XTANT MEDICAL HLDGS

 Performance 
       Timeline  
Diamyd Medical AB 

Risk-Adjusted Performance

6 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Diamyd Medical AB are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite nearly unsteady basic indicators, Diamyd Medical reported solid returns over the last few months and may actually be approaching a breakup point.
XTANT MEDICAL HLDGS 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days XTANT MEDICAL HLDGS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Diamyd Medical and XTANT MEDICAL Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Diamyd Medical and XTANT MEDICAL

The main advantage of trading using opposite Diamyd Medical and XTANT MEDICAL positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Diamyd Medical position performs unexpectedly, XTANT MEDICAL can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in XTANT MEDICAL will offset losses from the drop in XTANT MEDICAL's long position.
The idea behind Diamyd Medical AB and XTANT MEDICAL HLDGS pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.

Other Complementary Tools

Share Portfolio
Track or share privately all of your investments from the convenience of any device
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings